366 related articles for article (PubMed ID: 38634139)
1. The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance.
Tavakoli Pirzaman A; Alishah A; Babajani B; Ebrahimi P; Sheikhi SA; Moosaei F; Salarfar A; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2024; 23():15330338241239188. PubMed ID: 38634139
[TBL] [Abstract][Full Text] [Related]
2. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
[TBL] [Abstract][Full Text] [Related]
3. The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma.
Yang Q; Tian H; Guo Z; Ma Z; Wang G
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1697-1706. PubMed ID: 37867435
[TBL] [Abstract][Full Text] [Related]
4. Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review).
Wu J; Zhu Y; Cong Q; Xu Q
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083063
[TBL] [Abstract][Full Text] [Related]
5. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
6. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
7. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
Fang Y; Zhang X; Huang H; Zeng Z
J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.
Oura K; Morishita A; Masaki T
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.
Sun J; Lu H; Wang X; Jin H
ScientificWorldJournal; 2013; 2013():924206. PubMed ID: 23431261
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
[TBL] [Abstract][Full Text] [Related]
13. Exploring the mechanism of LncRNA CASC15 affecting hepatocellular carcinoma through miRNA.
Cai Q; Wu D; Shen Y; Li S; Liu L; Liu D; Li Y; Chen X; Wang L; Zheng J
Medicine (Baltimore); 2024 Feb; 103(5):e35859. PubMed ID: 38306545
[TBL] [Abstract][Full Text] [Related]
14. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
García-Vilas JA; Medina MÁ
World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
[TBL] [Abstract][Full Text] [Related]
15. Role of microRNAs in hepatocellular carcinoma.
Liu LN; Li DD; Xu HX; Zheng SG; Zhang XP
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1056-67. PubMed ID: 25961544
[TBL] [Abstract][Full Text] [Related]
16. Identification of Ppar
Winkler I; Bitter C; Winkler S; Weichenhan D; Thavamani A; Hengstler JG; Borkham-Kamphorst E; Kohlbacher O; Plass C; Geffers R; Weiskirchen R; Nordheim A
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):454-463. PubMed ID: 31871210
[TBL] [Abstract][Full Text] [Related]
17. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D
Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
Wu MN; Sun JY; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
[TBL] [Abstract][Full Text] [Related]
19. The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in the development of hepatocellular carcinoma and drug resistance.
Tricoli L; Niture S; Chimeh U; Ressom H; Kumar D
Front Biosci (Landmark Ed); 2019 Jan; 24(2):382-391. PubMed ID: 30468662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]